Hajnalka Jókai

Immunology and Microbiology · Life Sciences

10h-index476citations19works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(11), Health Systems, Economic Evaluations, Quality of Life(5), T-cell and B-cell Immunology(4), Dermatology and Skin Diseases(4), Cutaneous lymphoproliferative disorders research(4)

Publications19 total

Small molecule inhibitors – future perspectives in the treatment of hidradenitis suppurativa (HS)
Bőrgyógyászati és Venerológiai Szemle·2024Open Access
Burden of disease among psoriatic patients
Bőrgyógyászati és Venerológiai Szemle·2020Open Access
Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice
Advances in Dermatology and Allergology·2019· 8 citedOpen Access
A detailed analysis of ‘not relevant’ responses on the <scp>DLQI</scp> in psoriasis: potential biases in treatment decisions
Journal of the European Academy of Dermatology and Venereology·2017· 54 cited
317 Anti-drug antibody formation against biological agents in psoriasis
Journal of Investigative Dermatology·2016Open Access
Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC)
Journal of the American Academy of Dermatology·2016· 11 cited
The role of predictive markers in TNF-α inhibitor treatment of psoriasis
Bőrgyógyászati és Venerológiai Szemle·2015Open Access
Genitourethral infections caused by D–K serotypes of<i>Chlamydia trachomatis</i>
Orvosi Hetilap·2014· 2 cited
Moderate to severe psoriasis patients' subjective future expectations regarding health‐related quality of life and longevity
Journal of the European Academy of Dermatology and Venereology·2014· 29 citedOpen Access
Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients
Journal of the European Academy of Dermatology and Venereology·2014· 45 cited
Disease burden of psoriasis associated with psoriatic arthritis in Hungary
Orvosi Hetilap·2014· 13 citedOpen Access
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
The European Journal of Health Economics·2014· 40 citedOpen Access
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
The European Journal of Health Economics·2014· 96 citedOpen Access
A cutan lymphocyta-asszociált antigén (CLA) prediktív szerepe psoriasis TNF - α gátló kezelése során
Semmelweis University Repository (Semmelweis University)·2014Open Access
Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study
Journal of the American Academy of Dermatology·2013· 87 cited
Circulating <scp>CLA</scp>+ <scp>T</scp> lymphocytes as peripheral cell biomarkers in <scp>T</scp>‐cell‐mediated skin diseases
Experimental Dermatology·2013· 34 citedOpen Access
Cutaneous lymphocyte‐associated antigen as a novel predictive marker of <scp>TNF</scp>‐alpha inhibitor biological therapy in psoriasis
Experimental Dermatology·2013· 9 cited
Tissue-Specific Homing of Immune Cells in Malignant Skin Tumors
Pathology & Oncology Research·2012· 8 cited
Successful Treatment of Lichen Planus with Adalimumab
Acta Dermato Venereologica·2012· 40 citedOpen Access

Frequent Co-authors

Péter Holló(16), Sarolta Kárpáti(13), Krisztina Herszényi(9), Valentin Brodszky(7), Fanni Rencz(6), László Gulàcsi(5), Éva Remenyik(5), Emese Herédi(4), Márta Péntek(4), Andrea Szegedi(4), József Szakonyi(4), Orsolya Kontár(4), Márta Marschalkó(3), Orsolya Balogh(3), Bernadett Hídvégi(2), Judit Hársing(2), Judit Csomor(2), Krisztián Németh(2), Gábor Barna(2), Eszter Nagy(2)